BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11915173)

  • 1. Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer.
    Berghella AM; Contasta I; Pellegrini P; Del Beato T; Adorno D
    Cancer Biother Radiopharm; 2002 Feb; 17(1):43-50. PubMed ID: 11915173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
    Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.
    Kim YW; Kim SK; Kim CS; Kim IY; Cho MY; Kim NK
    Anticancer Res; 2014 Jul; 34(7):3481-7. PubMed ID: 24982357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of immunological evaluation in colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progression.
    Shimazaki J; Goto Y; Nishida K; Tabuchi T; Motohashi G; Ubukata H; Tabuchi T
    Oncology; 2013; 84(6):356-61. PubMed ID: 23689116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection.
    Heriot AG; Marriott JB; Cookson S; Kumar D; Dalgleish AG
    Br J Cancer; 2000 Mar; 82(5):1009-12. PubMed ID: 10737381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.
    Nebiker CA; Han J; Eppenberger-Castori S; Iezzi G; Hirt C; Amicarella F; Cremonesi E; Huber X; Padovan E; Angrisani B; Droeser RA; Rosso R; Bolli M; Oertli D; von Holzen U; Adamina M; Muraro MG; Mengus C; Zajac P; Sconocchia G; Zuber M; Tornillo L; Terracciano L; Spagnoli GC
    Clin Cancer Res; 2014 Jun; 20(12):3094-106. PubMed ID: 24737547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
    Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
    Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of colorectal cancer upon host peripheral immune cell function.
    Evans CF; Galustian C; Bodman-Smith M; Dalgleish AG; Kumar D
    Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation.
    Ohkawara Y; Lei XF; Stämpfli MR; Marshall JS; Xing Z; Jordana M
    Am J Respir Cell Mol Biol; 1997 May; 16(5):510-20. PubMed ID: 9160833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients].
    Wieloch M; Swiatkowska M; Libiszewski M; Hedayati M; Drozda R; Kołomecki K
    Pol Merkur Lekarski; 2009 Dec; 27(162):466-9. PubMed ID: 20120708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.